However, their study exclusively measured propionate production and did not assess broader metabolic changes, such as the levels of acetyl-CoA/acetylcarnitine, propionyl-CoA/propionylcarnitine, and methylcitrate during fasting
Lawsuits allege that some doctors encouraged off-label use of these medications for weight loss patients without providing adequate warnings about possible side effects like delayed gastric emptying, severe gastroparesis, and sudden vision loss
Al desarrollar nuevas lneas de productos, las empresas del sector salud enfrentan el desafo de seleccionar ingredientes respaldados por la ciencia, que ofrezcan resultados tangibles y que mantengan una alta estabilidad en sus procesos de manufactura
The arrival of GLP-1 drugs is not a panacea for obesity
The SUSTAIN trials assessed final once-weekly doses of 1.0 mg only, or 0.5 mg and 1.0 mg, of subcutaneous semaglutide (32)
That is a rare combination, and it is why rheumatologists are paying attention even though no randomized controlled trials specifically evaluating tirzepatide for autoimmune conditions exist yet